The total radioactivity concentrations in the kidney, liver, stomach wall, thymus, spleen, intestine, lung, skin, and body fat were reduced by approximately 50% compared with the peak concentration in the same tissue (1 h after administration)
The complete absence of human safety data for neurological applications, particularly long-term use affecting mental health, represents a critical knowledge gap
In my practice, 94% of children have been found to respond to Methyl-B12 therapy
Quick Take (TLDR) Mostly animal and in vitro data plus multiple very small uncontrolled human reports (knee pain case series n=16, interstitial cystitis pilot n=12, 2subject IV infusion) and no randomized controlled trials or published human pharmacokinetic profiles
We do not provide kits or instructions for unsupervised self-injection